Combination therapy for treating cancer with a recombinant poxvirus expressing a tumor antigen and an immune checkpoint molecule antagonist or agonist
- 专利权人:
- BAVARIAN NORDIC A/S
- 发明人:
- 申请号:
- IL24850716
- 公开号:
- IL248507D0
- 申请日:
- 2016.10.26
- 申请国别(地区):
- IL
- 年份:
- 2016
- 代理人:
- 摘要:
- The invention relates to compositions, kits, and methods for cancer therapy using recombinant poxviruses encoding a tumor-associated antigen in combination with antagonists or agonists of immune checkpoint inhibitors.
- 来源网站:
- 中国工程科技知识中心
相关发明人
相关专利
- Combination therapy for treating cancer with a recombinant poxvirus expressing a tumor antigen and an immune checkpoint molecule antagonist or agonist
- COMBINATION THERAPY FOR TREATING CANCER WITH A RECOMBINANT POXVIRUS EXPRESSING A TUMOR ANTIGEN AND AN IMMUNE CHECKPOINT MOLECULE ANTAGONIST OR AGONIST
- Combination Therapy for Treating Cancer with a Poxvirus Expressing a Tumor Antigen and an Antagonist and/or Agonist of an Immune Checkpoint Inhibitor
- Combination therapy for treating cancer with a poxvirus expressing a tumor antigen and an antagonist and/or agonist of an immune checkpoint inhibitor
- COMBINATION THERAPY FOR TREATING CANCER WITH POXVIRUS EXPRESSING TUMOUR ANTIGEN AND ANTAGONIST AND/OR AGONIST OF IMMUNE CHECKPOINT INHIBITOR